Holen Sie sich die Stockscreener-App
4.94
1.86%
0.09
Vorhandelsmarkt:
4.95
0.010
+0.20%
Schlusskurs vom Vortag:
$4.85
Offen:
$4.82
24-Stunden-Volumen:
1.60M
Relative Volume:
1.38
Marktkapitalisierung:
$631.65M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-54.89
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
-7.84%
1M Leistung:
+4.00%
6M Leistung:
+42.36%
1J Leistung:
-26.60%
1-Tages-Spanne:
$4.82
$5.045
1-Wochen-Bereich:
$4.79
$5.37
52-Wochen-Spanne:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.94 | 620.14M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Alle ansehen
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - Setenews
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
What dividend safety score for Cytek Biosciences Inc. stockPortfolio Profit Report & Long-Term Safe Investment Ideas - moha.gov.vn
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Cytek Biosciences Inc. (8EQ) stock a good hedge against inflationJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB) - Seeking Alpha
What technical charts say about Cytek Biosciences Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Why Cytek Biosciences Inc. (8EQ) stock is favored by hedge fundsAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Check Out Cytek BioSciences Inc (CTKB)’s Trade Data Rather Than the Analysts’ Views - Setenews
What technical models suggest about Cytek Biosciences Inc.’s comeback - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Does TIME Recognition Signal a Turning Point for Cytek Biosciences' (CTKB) Competitive Edge in Innovation? - Yahoo Finance
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):